Kaye Randall
Insider CIK 1350416 · AXSM Chief Medical Officer · LBPH Executive Vice President & CMO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 9,500 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 17,920 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 175,946 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 96,300 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 107,560 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | U Tender | 2024-12-02 | 2024-12-02 | 30,554 | $60.00 | $1.83M | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise deriv | 2024-11-19 | 2024-11-19 | 30,554 | — | $0 | 175,946 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise | 2024-11-19 | 2024-11-19 | 30,554 | $6.00 | $183.3K | 48,474 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2024-10-25 | 2024-10-29 | 9,500 | — | $0 | 9,500 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise deriv | 2024-10-15 | 2024-10-16 | 16,667 | — | $0 | 96,300 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | S Sale | 2024-10-15 | 2024-10-16 | 16,667 | $59.04 | $984.0K | 17,920 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise | 2024-10-15 | 2024-10-16 | 16,667 | $4.35 | $72.5K | 34,587 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise deriv | 2024-09-16 | 2024-09-16 | 16,666 | — | $0 | 112,967 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | S Sale | 2024-09-16 | 2024-09-16 | 4,200 | $31.81 | $133.6K | 21,020 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | S Sale | 2024-09-16 | 2024-09-16 | 9,366 | $30.89 | $289.3K | 25,220 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise | 2024-09-16 | 2024-09-16 | 16,666 | $4.35 | $72.5K | 34,586 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | S Sale | 2024-09-16 | 2024-09-16 | 1,900 | $34.04 | $64.7K | 17,920 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | S Sale | 2024-09-16 | 2024-09-16 | 1,200 | $33.12 | $39.7K | 19,820 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise deriv | 2024-08-12 | 2024-08-13 | 16,667 | — | $0 | 129,633 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | S Sale | 2024-08-12 | 2024-08-13 | 6,191 | $35.03 | $216.9K | 17,920 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | S Sale | 2024-08-12 | 2024-08-13 | 10,476 | $34.55 | $361.9K | 24,111 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | M Exercise | 2024-08-12 | 2024-08-13 | 16,667 | $4.35 | $72.5K | 34,587 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | S Sale | 2024-06-25 | 2024-08-13 | 100 | $20.87 | $2.1K | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2024-02-08 | 2024-02-09 | 107,560 | — | $0 | 107,560 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award | 2024-02-08 | 2024-02-09 | 17,920 | — | $0 | 17,920 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | P Buy | 2024-01-23 | 2024-08-13 | 100 | $24.82 | $2.5K | 100 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2023-02-09 | 2023-02-10 | 146,300 | — | $0 | 146,300 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2022-03-21 | 2022-03-21 | 206,500 | — | $0 | 206,500 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2015-12-23 | 2015-12-24 | 1,000 | $9.03 | $9.0K | 6,022 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2015-11-24 | 2015-11-24 | 5,022 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | C Conversion | 2015-11-24 | 2015-11-24 | 5,022 | $5.40 | $27.1K | 5,022 | SEC↗ |